Merck & Co., Inc.(MRK) Q3
EPS: 2.49 USD; Forecast 2.09 USD
Revenue: 18.09B USD; Forecast 17.33B USD
Reporting period: 2026 Q3 (period ended 2026-09-30)
Release date: 2026-10-29